Management of hypertension in older persons: what do the 2023/2024 European Society of Hypertension, 2024 European Society of Cardiology and 2025 American Heart Association/American College of Cardiology guidelines tell us?

Treatment of hypertension in older people is associated with significant health-related benefits. However, at very old age, in patients with frailty, multimorbidity, and polypharmacy, the benefits of treatment must be balanced against the potential for harm from adverse events. The evidence for treatment in such populations is limited because they typically have not been included in many clinical trials. In this article, we discuss the differences in the approach to management of hypertension in older patients between the three recent clinical guidelines: the European Society of Hypertension (2023-2024), European Society of Cardiology (2024) and the American Heart Association/American College of Cardiology (2025) guidelines. We conclude that the therapeutic approach to older persons should be personalized and should include a comprehensive evaluation of functionality and frailty. Balancing potential health-related benefits and harms should be the basis of all clinical decisions in this population, especially for individuals eluding simplistic classifications.

Authors

Institutions

Publication Details

Journal
Journal of Hypertension
Published
2026-11-17
DOI
https://doi.org/10.1097/hjh.0000000000004504
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Management of hypertension in older persons: what do the 2023/2024 European Society of Hypertension, 2024 European Society of Cardiology and 2025 American Heart Association/American College of Cardiology guidelines tell us?

James Peter Sheppard, Tomasz K. Grodzicki, Amela Kabaklić, Tine L.M. De Backer et al.
1 links
Journal of Hypertension
Blood Pressure and Hypertension Studies
article

Management of hypertension in older persons: what do the 2023/2024 European Society of Hypertension, 2024 European Society of Cardiology and 2025 American Heart Association/American College of Cardiology guidelines tell us?

James Peter Sheppard, Tomasz K. Grodzicki, Amela Kabaklić, Tine L.M. De Backer, Dhayana Dallmeier, Anna Kearney‐Schwartz, Karolina Piotrowicz, Jerzy Gąsowski, Heloísa Ribeiro, Athanasios Benetos, Gülistan Bahat
article en

Abstract

Treatment of hypertension in older people is associated with significant health-related benefits. However, at very old age, in patients with frailty, multimorbidity, and polypharmacy, the benefits of treatment must be balanced against the potential for harm from adverse events. The evidence for treatment in such populations is limited because they typically have not been included in many clinical trials. In this article, we discuss the differences in the approach to management of hypertension in older patients between the three recent clinical guidelines: the European Society of Hypertension (2023-2024), European Society of Cardiology (2024) and the American Heart Association/American College of Cardiology (2025) guidelines. We conclude that the therapeutic approach to older persons should be personalized and should include a comprehensive evaluation of functionality and frailty. Balancing potential health-related benefits and harms should be the basis of all clinical decisions in this population, especially for individuals eluding simplistic classifications.

Journal of Hypertension
Boston University (US), Jagiellonian University (PL), University of Ljubljana (SI), Inserm (FR), Ghent University Hospital (BE), Ljubljana University Medical Centre (SI), University of Oxford (GB), Unidade Local de Saúde de Entre Douro e Vouga (PT), Centre Hospitalier Régional et Universitaire de Nancy (FR), Agaplesion Bethesda Klinik (DE), University Hospital Ulm (DE), French Clinical Research Infrastructure Network (FR), Défaillance Cardiovasculaire Aiguë et Chronique (FR), Istanbul University (TR), Université de Lorraine (FR)
Good health and well-being
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon